ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,528Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 1187

$1.45M Total Retail Price of All Prescriptions

Rank: 12 out of 1187

668 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 668 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

2% of this provider’s 668 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 18,808 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 826 764 1 2
OMEPRAZOLE 674 585 2 5
SIMVASTATIN 635 604 3 1
METFORMIN HCL 555 456 4 7
LEVOTHYROXINE SODIUM 543 461 5 3
WARFARIN SODIUM 481 481 6 13
ATORVASTATIN CALCIUM 444 368 7 6
LISINOPRIL 442 388 8 4
CARVEDILOL 432 396 9 19
LOSARTAN POTASSIUM 430 340 10 21
ALENDRONATE SODIUM 415 401 11 25
PRAVASTATIN SODIUM 365 289 12 12
METOPROLOL SUCCINATE 342 277 13 11
HYDROCHLOROTHIAZIDE 341 283 14 9
ZOLPIDEM TARTRATE 332 306 15 14
DONEPEZIL HCL 328 325 16 26
DIOVAN 326 300 17 17
DIOVAN HCT 291 276 18 40
METOPROLOL TARTRATE 262 217 19 10
NABUMETONE 239 212 20 149
JANUVIA 228 197 21 34
EVISTA 219 206 22 114
TRAMADOL HCL 215 205 23 28
MELOXICAM 212 193 24 49
CLOPIDOGREL 206 183 25 33
NAMENDA 193 193 26 44
ADVAIR DISKUS 190 151 27 35
LOSARTAN-HYDROCHLOROTHIAZIDE 187 153 28 56
RAMIPRIL 186 139 29 36
ACTOS 186 151 29 101
CELEBREX 183 165 31 68
CRESTOR 180 157 32 16
FUROSEMIDE 180 154 32 8
FLUTICASONE PROPIONATE 176 145 34 31
PLAVIX 171 151 35 52
GLIMEPIRIDE 164 138 36 30
TAMSULOSIN HCL 163 150 37 29
SINGULAIR 160 130 38 67
NEXIUM 147 105 39 15
AZITHROMYCIN 134 102 40 24
ENALAPRIL MALEATE 133 126 41 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 130 106 42 39
PANTOPRAZOLE SODIUM 130 115 42 42
DIGOXIN 129 115 44 65
MONTELUKAST SODIUM 127 107 45 129
LIPITOR 126 102 46 43
SERTRALINE HCL 125 106 47 22
MIRTAZAPINE 125 125 47 54
GABAPENTIN 124 96 49 23
ZETIA 118 107 50 64
CITALOPRAM HBR 113 113 51 45
NAPROXEN 112 69 52 72
ALLOPURINOL 110 104 53 50
MECLIZINE HCL 106 83 54 112
NATEGLINIDE 105 97 55 192
ATENOLOL 105 95 55 18
LYRICA 105 84 55 91
POTASSIUM CHLORIDE 103 63 58 32
BENAZEPRIL HCL 100 82 59 142
GLIPIZIDE ER 94 91 60 115
FLECTOR 87 87 61 335
GLIPIZIDE XL 85 61 62 117
PREDNISONE 84 76 63 61
OXYBUTYNIN CHLORIDE ER 81 71 64 118
FAMOTIDINE 81 64 64 48
ALBUTEROL SULFATE 81 81 64 120
LANTUS SOLOSTAR 80 64 67 92
NIASPAN 78 64 68 145
LOVAZA 78 58 68 53
PROAIR HFA 78 49 68 41
LIDODERM 77 71 71 80
CYMBALTA 73 59 72 60
EXFORGE 73 70 72 140
LEVOCETIRIZINE DIHYDROCHLORIDE 71 62 74 166
RANITIDINE HCL 70 62 75 69
MEGACE ES 68 68 R 76 240
ESCITALOPRAM OXALATE 65 60 77 51
LANTUS 65 65 77 77
ISOSORBIDE MONONITRATE ER 64 46 79 66
DEXILANT 63 50 80 137
JANUMET 62 45 81 111
VOLTAREN 61 57 82 126
LATANOPROST 60 60 83 243
PIOGLITAZONE HCL 59 53 R 84 285
QUETIAPINE FUMARATE 59 59 84 75
FEXOFENADINE HCL 57 56 86 212
FINASTERIDE 57 57 86 110
AVODART 56 56 88 231
EXELON 56 56 88 132
AMLODIPINE BESYLATE-BENAZEPRIL 55 53 90 62
PRADAXA 54 48 91 199
IBANDRONATE SODIUM 53 53 92 191
IPRATROPIUM BROMIDE 52 52 93 197
LANSOPRAZOLE 52 37 93 172
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.